Spark Therapeutics | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
Spark Therapeutics | 15-12B: Notice of termination of registration of a class of securities under Section 12(b) (and amendment thereto)
Spark Therapeutics | 3: Initial statement of beneficial ownership of securities
Spark Therapeutics | 4: Statement of changes in beneficial ownership of securities
Spark Therapeutics | 4: Statement of changes in beneficial ownership of securities
Spark Therapeutics | 4: Statement of changes in beneficial ownership of securities
Spark Therapeutics | 4: Statement of changes in beneficial ownership of securities
Spark Therapeutics | 4: Statement of changes in beneficial ownership of securities
Spark Therapeutics | 4: Statement of changes in beneficial ownership of securities
Spark Therapeutics | 4: Statement of changes in beneficial ownership of securities
Spark Therapeutics | 4: Statement of changes in beneficial ownership of securities
Spark Therapeutics | 4: Statement of changes in beneficial ownership of securities
Spark Therapeutics | 4: Statement of changes in beneficial ownership of securities
Spark Therapeutics | 4: Statement of changes in beneficial ownership of securities
Spark Therapeutics | 4: Statement of changes in beneficial ownership of securities
Spark Therapeutics | 4: Statement of changes in beneficial ownership of securities
Spark Therapeutics | S-8 POS: S-8 POS
Spark Therapeutics | 4: Statement of changes in beneficial ownership of securities
Spark Therapeutics | S-8 POS: S-8 POS
Spark Therapeutics | S-8 POS: S-8 POS
No Data